Kapstone Financial Advisors »

AstraZeneca shares owned by Kapstone Financial Advisors

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Kapstone Financial Advisors from 13F filings

Historical chart of Kapstone Financial Advisors investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Kapstone Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Kapstone Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $203k 2.6k 77.62
2024-06-30 $204k 2.6k 77.99

More positions owned by Kapstone Financial Advisors

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microstrategy Cl A New (MSTR)
Ishares Tr Core High Dv Etf (HDV)
Procter & Gamble Company (PG)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr Select Divid Etf (DVY)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Rus 1000 Grw Etf (IWF)
Alphabet Cap Stk Cl A (GOOGL)
Abbvie (ABBV)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Kapstone Financial Advisors

Top funds holding AstraZeneca

T. Rowe Price Associates
PRIMECAP Management Company
Capital Research and Management Company - Division 3
Franklin Resources
Jennison Associates
Sanders Capital
Goldman Sachs Group
Morgan Stanley
Fisher Investments
Atlantic Trust
Bank of America Corporation
BlackRock
Capital World Investors
BlackRock
GQG Partners

View all funds holding AstraZeneca